1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Akebia Therapeutics Inc (AKBA)

  7. Akebia Therapeutics Inc (AKBA) Financials

AKBA

Akebia Therapeutics Inc
0.59
-0.0093 (-1.55%)
Upgrade to Real-Time

Akebia Therapeutics Inc. (AKBA) Fundamentals
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.
SHARE INFORMATION
Market CapUS$ 110,419,853
Shares Outstanding184,248,045
Float182,297,059
Percent Float98.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 292,602,000
Latest Fiscal EPSUS$ -0.52
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions249
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months1,996,399
Institutional Holdings Percent38.6%
Institutional Sold Previous 3 Months30,374,815
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months2,784,438
Insider Holdings Percent2.7
Insider Sold Previous 3 Months-
Insider Shares Owned4,970,694
TRADING INFO
52 Week HighUS$ 2.60
52 Week LowUS$ 0.24
52 Week High ChangeUS$ -75.44
21 Day Moving AverageUS$ 0.7738
21 Day Extended Moving AverageUS$ 0.727519
50 Day Moving AverageUS$ 0.7944
50 Day Extended Moving AverageUS$ 0.728483
200 Day Moving AverageUS$ 0.477776
200 Day Extended Moving AverageUS$ 0.736946
10 Day Average Volume1,071,309
20 Day Average Volume1,770,116
30 Day Average Volume2,005,272
50 Day Average Volume2,318,368
Alpha-0.010225
Beta0.8315
Standard Deviation0.280387
R20.025502
7 Day Price ChangeUS$ -0.1007
7 Day Percent Change-14.39%
21 Day Price ChangeUS$ -0.3463
21 Day Percent Change-36.62%
30 Day Price ChangeUS$ -0.2434
30 Day Percent Change-28.88%
Month to Date Price ChangeUS$ -0.2434
Month to Date Percent Change-28.88%
Quarter to Date Price ChangeUS$ 0.0223
Quarter to Date Percent Change3.86%
180 Day Price ChangeUS$ 0.2693
180 Day Percent Change81.61%
200 Day Price ChangeUS$ 0.1642
200 Day Percent Change37.74%
Year to Date Price ChangeUS$ 0.0223
Year to Date Percent Change3.86%

Akebia Therapeutics Inc. (AKBA) Key Ratios

PROFITABILITY
EBIT Margin-46.8%
EBITDA Margin-34.1%
Pre-Tax Profit Margin-89.7%
Profit Margin Count-31.45%
Gross Margin71.0%
Profit Margin TOT-31.45%
INCOME STATEMENTS
RevenueUS$ 292,602,000
Revenue Per ShareUS$ 1.5881
Revenue (3 Years)US$ -7.04
Revenue (5 Years)US$ 7.23
FINANCIAL STRENGTH
Price to Tangible Book-1.00
Total Debt To Equity10.70
Int Coverage-4.90
Current Ratio1.50
Leverage Ratio16.60
Quick Ratio1.00
Long Term Debt To Capital0.87
VALUATION MEASURES
PE Ratio-0.90
Enterprise ValueUS$ 127,014,651
Price to Sales0.377372
Price to Free Cash-1.60
PE High Last 5 Years-1.70
Price To Book12.60
Price To Cash Flow10.50
PE Low Last 5 Years-3.00
Price to Tangible Book-1.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.30
Invoice Turnover2.90
Assets Turnover0.70
Return Assets-21.84
Return on Equity-227.25
Return on Capital-83.01

Akebia Therapeutics Inc. (AKBA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJohn P. Butler
Emplyoees426
Last AuditUQ
CIK0001517022
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address245 First Street
Suite 1100
Cambridge, MA 2142
Websitehttps://www.akebia.com
Facsimile+1 617 871-2099
Telephone+1 617 871-2098
Emailir@akebia.com
Your Recent History
NASDAQ
AKBA
Akebia The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230329 14:17:39